A Case of Type 1 Glycogen Storage Disease with Increased Serum and Urinary C-Peptide Levels

Yoshiyuki Sakai, Kaoru Inoue, Naoki Nakashima, Fujiko Hayashi, Takaaki Hisatomi, Kensaku Sekiya, Bunei Ando, Masao Ohashi, Fumio Umeda, Hajime Nawata

Research output: Contribution to journalArticle

Abstract

A 30-year-old woman was admitted for evaluation of hepatic function. Hepatomegaly in this patient was originally pointed out when she was one year old. On admission, her liver was palpable 5 f. b. below the costal margin in the right midclavicular line. She was diagnosed as having glycogen storage disease type 1 on the basis of changes in serum lactate levels in response to glucose ingestion and glucagon administration. Her fasting plasma glucose level was 66 mg/d? and her HbA1C level was 4.0%. The concentration of serum insulin increased slightly from 4.6 U/m? to 19.8 U/m? in response to an injection of 75 g glucose, whereas the concentration of serum C-peptide increased markedly from 1.0 ng/m? to 8.4 ng/m?. In addition, urinary excretion ot C-peptide was remarkably elevated varying from 253 g/day to 268 g/day. As to glucagon secretion, no response of plasma glucagon to hypoglycemia induced by insulin administration was observed, whereas the response of glucagon to arginine administration was normal. This patient is thought to be a rare case of glycogen storage disease type 1 with high levels of serum and urinary C-peptide and with an insensitivity of glucagon secretion to hypoglycemia.

Original languageEnglish
Pages (from-to)495-500
Number of pages6
JournalJournal of the Japan Diabetes Society
Volume35
Issue number6
DOIs
Publication statusPublished - Jan 1 1992

Fingerprint

Glycogen Storage Disease Type I
C-Peptide
Glucagon
Serum
Hypoglycemia
Glucose
Insulin
Hepatomegaly
Liver
Arginine
Lactic Acid
Fasting
Eating
Injections

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

A Case of Type 1 Glycogen Storage Disease with Increased Serum and Urinary C-Peptide Levels. / Sakai, Yoshiyuki; Inoue, Kaoru; Nakashima, Naoki; Hayashi, Fujiko; Hisatomi, Takaaki; Sekiya, Kensaku; Ando, Bunei; Ohashi, Masao; Umeda, Fumio; Nawata, Hajime.

In: Journal of the Japan Diabetes Society, Vol. 35, No. 6, 01.01.1992, p. 495-500.

Research output: Contribution to journalArticle

Sakai, Y, Inoue, K, Nakashima, N, Hayashi, F, Hisatomi, T, Sekiya, K, Ando, B, Ohashi, M, Umeda, F & Nawata, H 1992, 'A Case of Type 1 Glycogen Storage Disease with Increased Serum and Urinary C-Peptide Levels', Journal of the Japan Diabetes Society, vol. 35, no. 6, pp. 495-500. https://doi.org/10.11213/tonyobyo1958.35.495
Sakai, Yoshiyuki ; Inoue, Kaoru ; Nakashima, Naoki ; Hayashi, Fujiko ; Hisatomi, Takaaki ; Sekiya, Kensaku ; Ando, Bunei ; Ohashi, Masao ; Umeda, Fumio ; Nawata, Hajime. / A Case of Type 1 Glycogen Storage Disease with Increased Serum and Urinary C-Peptide Levels. In: Journal of the Japan Diabetes Society. 1992 ; Vol. 35, No. 6. pp. 495-500.
@article{11590d75c61342ac9f479aac0c024443,
title = "A Case of Type 1 Glycogen Storage Disease with Increased Serum and Urinary C-Peptide Levels",
abstract = "A 30-year-old woman was admitted for evaluation of hepatic function. Hepatomegaly in this patient was originally pointed out when she was one year old. On admission, her liver was palpable 5 f. b. below the costal margin in the right midclavicular line. She was diagnosed as having glycogen storage disease type 1 on the basis of changes in serum lactate levels in response to glucose ingestion and glucagon administration. Her fasting plasma glucose level was 66 mg/d? and her HbA1C level was 4.0{\%}. The concentration of serum insulin increased slightly from 4.6 U/m? to 19.8 U/m? in response to an injection of 75 g glucose, whereas the concentration of serum C-peptide increased markedly from 1.0 ng/m? to 8.4 ng/m?. In addition, urinary excretion ot C-peptide was remarkably elevated varying from 253 g/day to 268 g/day. As to glucagon secretion, no response of plasma glucagon to hypoglycemia induced by insulin administration was observed, whereas the response of glucagon to arginine administration was normal. This patient is thought to be a rare case of glycogen storage disease type 1 with high levels of serum and urinary C-peptide and with an insensitivity of glucagon secretion to hypoglycemia.",
author = "Yoshiyuki Sakai and Kaoru Inoue and Naoki Nakashima and Fujiko Hayashi and Takaaki Hisatomi and Kensaku Sekiya and Bunei Ando and Masao Ohashi and Fumio Umeda and Hajime Nawata",
year = "1992",
month = "1",
day = "1",
doi = "10.11213/tonyobyo1958.35.495",
language = "English",
volume = "35",
pages = "495--500",
journal = "Journal of the Japan Diabetes Society",
issn = "0021-437X",
publisher = "Japan Diabetes Society",
number = "6",

}

TY - JOUR

T1 - A Case of Type 1 Glycogen Storage Disease with Increased Serum and Urinary C-Peptide Levels

AU - Sakai, Yoshiyuki

AU - Inoue, Kaoru

AU - Nakashima, Naoki

AU - Hayashi, Fujiko

AU - Hisatomi, Takaaki

AU - Sekiya, Kensaku

AU - Ando, Bunei

AU - Ohashi, Masao

AU - Umeda, Fumio

AU - Nawata, Hajime

PY - 1992/1/1

Y1 - 1992/1/1

N2 - A 30-year-old woman was admitted for evaluation of hepatic function. Hepatomegaly in this patient was originally pointed out when she was one year old. On admission, her liver was palpable 5 f. b. below the costal margin in the right midclavicular line. She was diagnosed as having glycogen storage disease type 1 on the basis of changes in serum lactate levels in response to glucose ingestion and glucagon administration. Her fasting plasma glucose level was 66 mg/d? and her HbA1C level was 4.0%. The concentration of serum insulin increased slightly from 4.6 U/m? to 19.8 U/m? in response to an injection of 75 g glucose, whereas the concentration of serum C-peptide increased markedly from 1.0 ng/m? to 8.4 ng/m?. In addition, urinary excretion ot C-peptide was remarkably elevated varying from 253 g/day to 268 g/day. As to glucagon secretion, no response of plasma glucagon to hypoglycemia induced by insulin administration was observed, whereas the response of glucagon to arginine administration was normal. This patient is thought to be a rare case of glycogen storage disease type 1 with high levels of serum and urinary C-peptide and with an insensitivity of glucagon secretion to hypoglycemia.

AB - A 30-year-old woman was admitted for evaluation of hepatic function. Hepatomegaly in this patient was originally pointed out when she was one year old. On admission, her liver was palpable 5 f. b. below the costal margin in the right midclavicular line. She was diagnosed as having glycogen storage disease type 1 on the basis of changes in serum lactate levels in response to glucose ingestion and glucagon administration. Her fasting plasma glucose level was 66 mg/d? and her HbA1C level was 4.0%. The concentration of serum insulin increased slightly from 4.6 U/m? to 19.8 U/m? in response to an injection of 75 g glucose, whereas the concentration of serum C-peptide increased markedly from 1.0 ng/m? to 8.4 ng/m?. In addition, urinary excretion ot C-peptide was remarkably elevated varying from 253 g/day to 268 g/day. As to glucagon secretion, no response of plasma glucagon to hypoglycemia induced by insulin administration was observed, whereas the response of glucagon to arginine administration was normal. This patient is thought to be a rare case of glycogen storage disease type 1 with high levels of serum and urinary C-peptide and with an insensitivity of glucagon secretion to hypoglycemia.

UR - http://www.scopus.com/inward/record.url?scp=85008112199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008112199&partnerID=8YFLogxK

U2 - 10.11213/tonyobyo1958.35.495

DO - 10.11213/tonyobyo1958.35.495

M3 - Article

AN - SCOPUS:85008112199

VL - 35

SP - 495

EP - 500

JO - Journal of the Japan Diabetes Society

JF - Journal of the Japan Diabetes Society

SN - 0021-437X

IS - 6

ER -